Get 40% Off
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list

Chembio Diagnostics Inc (CEMI)

NASDAQ
Currency in USD
Disclaimer
0.455
0.000(0.00%)
Closed

CEMI Comments

Chembio Diagnostics Inc - on December 21, FDA Notified Co That It Was Declining to Review Co's Application for Eua for Dpp Respiratory Antigen Panel. Chembio -fda Notice Said Co Will Need to Collect Influenza a & Influenza B Samples, Submit New Eua Application for Dpp Respiratory Antigen Panel.
Any news?
Chembio Diagnostics (CEMI) gains 9.5% premarket after receiving South Africa Health Products Regulatory Authority ((SAHPRA)) approval for the DPP SARS-CoV-2 Antigen test,...
up up
HAUPPAUGE, N.Y., Nov. 15, 2021 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. ("Chembio") (NASDAQ:CEMI), a leading point-of-care diagnostics company focused on infectious diseases, today announced that the delivery schedule for shipments of DPP SARS-COV-2 Antigen Tests under its July 2021 purchase order from Bio Manguinhos has been extended into March 2021. As the result of a portion of the shipments now being deliverable after year end, Chembio believes it now has the opportunity to fulfill all of the $28.3 million order. Chembio's delivery of tests covered by the purchase order, however, continues to be negatively affected by limitations of Chembio's supply chain, staffing, and liquidity, and other matters outside Chembio's control.
But I expect a rapid rise in the near future... I expect to sign an agreement to manufacture Covid devices
bad report
2 Major orders in this last Quarter Why is this stock not going up? what am i missing thats not in the news?
2.59 good to buy in my opinion
hm hm hm
👍👍👍👍👍
I think there is a big explosion coming soon
Break coming around 1130
🚀
Selling at 7.5 $
Chembio Diagnostics Inc (NASDAQ: CEMI) has launched the commercial distribution of an FDA-Emergency Use Authorized rapid point-of-care COVID-19 antigen test.  Product inventory is on-hand and immediately available for shipment to Chembio customers ...
Vol is off the hook
otw to usd4
Is just me or this taking the exact same path as sprt.
So how much do u expect
15 to 20
Hum could be a Interesting day
The world wants what they have. A test that can tell differnce between covid and Influenza.
my target sell 3.5 vary soon
loding
invest guys this is cheap
Shorts wont let this one get lose again.
keep giving false hope to people, i know you are getting paid under the table from Chembio to keep pumping wrong info. People wont fall for the same traps over and over again...
No im not getting paid sundhine
I wish Im paid lol last loaded at 2.50
...
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.